Patients and Data
The Prostate biobank is currently collecting samples and data from approximately 300 patients undergoing radical prostatectomy annually. As of August 2017, the biobank contains 2500 FFPE samples and 1300 FF samples.
| PSA | PSA <10 | 10< PSA >20 | PSA >20 | Total |
| n= | 751 | 370 | 86 | 1207 |
| Gleason biopsy | 1 | 2 | 3 | 4 | 5 | Total |
| n= | 508 | 413 | 140 | 129 | 17 | 1207 |
| Gleason RP | 1 | 2 | 3 | 4 | 5 | Total |
| n= | 381 | 476 | 219 | 94 | 31 | 1207 |
| pT-stage | pT1c | pT2 | pT3a | pT3b | pT4 | Total |
| n= | 4 | 710 | 384 | 103 | 2 | 1207 |
The Prostate Biobank study has approvals and consent is in place to retrieve and link data also to a range of nationwide and mandatory registries such as the Cancer Registry of Norway, The Norwegian Cause of Death Registry (NCoDR), The Norwegian Prescription Database (NorPD) and The Norwegian Patient Registry (NPR). Deeper-level clinical and phenotype data can also be obtained directly from hospital EMRs.